Absence of lower urinary tract symptoms is an independent predictor for cancer at prostate biopsy, but prostate-specific antigen is not: Results from a prospective series of 569 patients

Clinical Prostate Cancer

Volumn 4, Issue 1, 2005, Pages 50-54

  Porter, Christopher R ^a   Latchamsetty, Kalyan C ^a   Coogan, Christopher L ^b   Kim, Jason ^c  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

American Urologic Association Symptom Score; Digital rectal examination; Needle biopsy; Ultrasound

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; AMERICAN UROLOGIC ASSOCIATION SYMPTOM SCORE; ARTICLE; CANCER DIAGNOSIS; CAUCASIAN; DIGITAL RECTAL EXAMINATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEEDLE BIOPSY; NEGRO; PREDICTION; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; RACE; SCORING SYSTEM; SYMPTOMATOLOGY; TRANSRECTAL ULTRASONOGRAPHY; URINARY TRACT DISEASE; VOLUMETRY;

EID: 22544454441     PISSN: 15400352     EISSN: None     Source Type: Journal    
DOI: 10.3816/CGC.2005.n.012     Document Type: Article

References (16)

1. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin 2004; 54:8-29.
2. Keetch DW, Catalona WJ, Smith DS. Serial prostate biopsies in men with persistently elevated serum prostate specific antigen values. J Urol 1994; 151:1571-1574.
3. Catalona WJ, Richie JP, Ahmann FR, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol 1994; 151:1283-1290.
4. Bostwick DG. Prostate needle biopsy: squeezing information from threads of tissue. Semin Urol Oncol 1999; 17:175-176.
5. Barry MJ, Fowler FJ, O'Leary MP, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 1992; 148:1549-1557.
6. Rabbani F, Stroumbakis N, Kava BR, et al. Incidence and significance of false-negative sextant prostate biopsies. J Urol 1998; 159:1247-1250.
7. Gore JL, Shariat S, Miles B, et al. Optimal combinations of systematic sex-tant and laterally-directed biopsies for the detection of prostate cancer. J Urol 2001; 165:1554-1559.
8. Wilt TJ. Clarifying uncertainty regarding detection and treatment of early stage prostate cancer. Semin Urol Oncol 2002; 20:10-17.
9. Porter CR, Kim J. Low AUA symptom score independently predicts positive prostate needle biopsy: results from a racially diverse series of 411 patients. Urology 2004; 63:90-94.
10. Stamey TA, Johnstone IM, McNeal JE, et al. Preoperative serum prostate specific antigen levels between 2 and 22 ng/ml correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng/ml. J Urol 2002; 167:103-111.
11. Lin TP, Huang WJ, Chen KK. Differentiation of benign prostatic hyperplasia from prostate cancer using prostate specific antigen dynamic profile after transrectal prostate biopsy. J Urol 2004; 171:2226-2229.
12. Wright EJ, Fang J, Metter EJ, et al. Prostate specific antigen predicts the long-term risk of prostate enlargement: results from the Baltimore Longitudinal Study of Aging. J Urol 2002; 167:2484-2488.
13. Mebust WK. Symptoms, evaluation, quality of life and sexuality. In: Crockett AT, Khoury S, Aso Y, eds. Proceedings of the Third International Consultation on BPH (Monaco, June 25-28, 1995). Jersey, Channel Islands: Scientific Communications International, World Health Organization, 1996:255-296.
14. Riehmann M, Hansen BJ, Polishuk PV, et al. Symptom scores in benign prostatic hyperplasia. Urology 1997; 49:10-18.
15. Brown CT, O'Flynn E, van der Meulen J, et al. The fear of prostate cancer in men with lower urinary tract symptoms: should symptomatic men be screened? BJU Int 2003; 91:30-32.
16. Meigs JB, Barry MJ, Giovannucci E, et al. High rates of prostate specific antigen testing in men with evidence of benign prostatic hyperplasia. Am J Med 1998; 104:517-525.